New Haven, Conn.-based Yale Cancer Center and Smilow Cancer Hospital have appointed Ian Krop, MD, PhD, section chief of medical oncology and hematology. Dr. Krop will also serve as deputy director for clinical affairs, according to a June 15 news…
The Latest
Patient balances continue to rise, but adding billing staff isn’t a sustainable answer for growing dental organizations. Many billing teams are stuck chasing payments manually, balancing patient communications across multiple locations, and trying to improve collections in a challenging labor…
Jul 29, 2026 12:00 PM - 1:00 PM CDT
Presented by:
Presenters
Pam Draper
Samantha Champagnie
Aphton McElheney
Cambridge, Mass.-based Harvard University was ranked the top university for oncology — both globally and in the U.S. — as part of U.S. News & World Report’s “2026-2027 Best Global Universities” rankings. Harvard University also earned the top spot for…
Carle Illinois College of Medicine, part of Urbana-based University of Illinois, has established a research program combining the science of cancer treatment and regenerative medicine. The Translational Oncology and Regenerative Medicine Laboratory will be led by Mark Cohen, MD, dean…
Most health systems still treat pharmacy as a line-item expense to control. Leaders at Ochsner Health, St. Luke’s Health System, MetroHealth and Yale New Haven Health System are taking a different approach—leveraging pharmacy intelligence, AI-enabled workflows and data-driven decision-making to improve medication…
Jul 15, 2026 12:00 PM - 1:00 PM CDT
Presented by:
Presenters
Deborah Simonson, PharmD, CPEL
Joshua Weber, PharmD, MBA-HCM, CSP, BCMTMS, 340B ACE
Ryan Mezinger, RPh, CPEL
Marjorie Lazarre, PharmD, MHA
Kentucky and West Virginia had the highest cancer death rates in 2024, according to CDC data. Hawaii had the lowest cancer death rate in 2024, followed by Utah. Here are the age-adjusted cancer death rates per 100,000 people in 2024,…
Kansas City, Mo.-based Children’s Mercy has appointed Yong Li, PhD, inaugural division director of the newly established Molecular Oncology and Cellular Therapeutics program. He has also been appointed the first Paul and Linda DeBruce Endowed Chair in Cancer Immunotherapy, according…
Compared to patients with private insurance, patients with Medicaid and Medicare coverage had higher in-hospital mortality rates after receiving CAR T-cell therapy, according to an abstract presented at the American Society of Clinical Oncology’s 2026 annual meeting. Researchers from Valhalla,…
For independent practices, denials don’t just delay payments. They drain staff time, strain margins and create backlogs that take weeks to unwind. The financial impact is visible in A/R reports. The operational impact is felt in every billing cycle. Most…
On Demand
Presented by:
Presenters
Michelle Scott
AVP RCS Operations, Veradigm
Houston Methodist has tapped Malcolm Brenner, MD, PhD, as the inaugural leader of the Houston Methodist Center for Cell and Gene Therapy. The new center will bring together Houston Methodist researchers, scientists, clinicians and support staff, according to a June…